Related Experiment Videos
Emilie Steentoft Dahlberg1, Dorte Andersen2, Pernilla Skjødt Andersson3
1Gynækologisk-Obstetrisk Afdeling, Københavns Universitetshospital - Hvidovre Hospital.
Ugeskrift for Laeger
|October 24, 2023
Summary
Letrozole (LTZ) is recommended for fertility treatments, including intrauterine insemination and in vitro fertilization, particularly for women with ovulatory dysfunction. It shows comparable efficacy to clomiphene and can be an alternative to gonadotropins.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Background:
- Letrozole (LTZ) is an aromatase inhibitor with established roles in fertility treatment.
- Evidence is accumulating on its diverse applications beyond initial indications.
Conclusions:
- Letrozole is a versatile agent in fertility management, applicable across multiple treatment protocols.
- Its use is expanding, particularly in conjunction with assisted reproductive technologies and for specific ovulatory disorders.